Cargando…
Low-molecular-mass secretome profiling identifies HMGA2 and MIF as prognostic biomarkers for oral cavity squamous cell carcinoma
The profiling of cancer cell secretomes is considered to be a good strategy for identifying cancer-related biomarkers, but few studies have focused on identifying low-molecular-mass (LMr) proteins (<15 kDa) in cancer cell secretomes. Here, we used tricine–SDS-gel-assisted fractionation and LC–MS/...
Autores principales: | Chang, Kai-Ping, Lin, Shih-Jie, Liu, Shiau-Chin, Yi, Jui-Shan, Chien, Kun-Yi, Chi, Lang-Ming, Kao, Huang-Kai, Liang, Ying, Lin, Yu-Tsun, Chang, Yu-Sun, Yu, Jau-Song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650660/ https://www.ncbi.nlm.nih.gov/pubmed/26138061 http://dx.doi.org/10.1038/srep11689 |
Ejemplares similares
-
Plasma Matrix Metalloproteinase-1 as a Prognostic Biomarker in Oral Cavity Squamous Cell Carcinoma
por: Tsai, Tsung-You, et al.
Publicado: (2022) -
Nomogram based on albumin and neutrophil-to-lymphocyte ratio for predicting the prognosis of patients with oral cavity squamous cell carcinoma
por: Kao, Huang-Kai, et al.
Publicado: (2018) -
Genomic and Molecular Signatures of Successful Patient-Derived Xenografts for Oral Cavity Squamous Cell Carcinoma
por: Yen, Wei-Chen, et al.
Publicado: (2022) -
Discovering the Clinical and Prognostic Role of Pan-Immune-Inflammation Values on Oral Cavity Squamous Cell Carcinoma
por: Yeh, Chia-Chi, et al.
Publicado: (2023) -
HMGA1 regulates the Plasminogen activation system in the secretome of breast cancer cells
por: Resmini, Giulia, et al.
Publicado: (2017)